Literature DB >> 6254037

Mapping of transforming region of the Harvey murine sarcoma virus genome by using insertion-deletion mutants constructed in vitro.

C M Wei, D R Lowy, E M Scolnick.   

Abstract

Circular DNA intermediates of Harvey murine sarcoma virus (Ha-MuSV) have been cloned in lambda gtWES . lambda B and shown to be capable of transforming mouse NIH 3T3 cells [Hager, G. L., Chang, E. H., Chan, H. W., Garon, C. F., Israel, M. A., Martin, M. A., Scolnick, E. M. & Lowy, D. R. (1979) J. Virol. 31, 795-809]. By using the cloned Ha-MuSV DNA insert as a parental genome, we have constructed a series of insertion-deletion mutants by inserting an octomer containing the Sal I linker sequence (G-G-T-C-G-A-C-C) into various regions of the Ha-MuSV genome after partial digestion with Hae III. After ligation into lambda gtWES . lambda B-Sal I vector molecules, the mutant Ha-MuSV DNAs were cloned. Fourteen insertion-deletion mutants have been mapped by restriction enzyme digestion, and their biological activities have been correlated with the locations of mutations. The mutants whose lesion mapped within 3.0 kilobases (kb) frm the 3'-end of the Ha-MuSV genome retained full transforming ability. The mutants containing the Sal I linker insertion at 0.4 or 1.5 kb from the 5'-end also retained transforming ability, but the number of foci induced by the DNAs in transfection assays was greatly reduced. However, a mutant containing a deletion of 1.5 kb at the 5'-end and a mutant with a deletion of the sequences between 1.0 and 1.5 kb from the 5'-end completely lost their transforming potential. A model for the transforming region of Ha-MuSV is discussed. Furthermore, because Ha-MuSV sequences can be rescued from the mouse cells transformed by these mutants using Moloney murine leukemia virus as a helper virus, it implies that the in vitro modified DNAs may be converted into genuine mutant viruses.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6254037      PMCID: PMC349908          DOI: 10.1073/pnas.77.8.4674

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Preparation and characterization of highly radioactive in vitro labeled adenovirus DNA and DNA restriction fragments.

Authors:  J K Mackey; K H Brackmann; M R Green; M Green
Journal:  Biochemistry       Date:  1977-10-04       Impact factor: 3.162

3.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  EK2 derivatives of bacteriophage lambda useful in the cloning of DNA from higher organisms: the lambdagtWES system.

Authors:  P Leder; D Tiemeier; L Enquist
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Safer derivatives of bacteriophage lambdagt-lambdaC for use in cloning of recombinant DNA molecules.

Authors:  L Enquist; D Tiemeier; P Leder; R Weisberg; N Sternberg
Journal:  Nature       Date:  1976-02-19       Impact factor: 49.962

7.  Mapping RNase T1-resistant oligonucleotides of avian tumor virus RNAs: sarcoma-specific oligonucleotides are near the poly(A) end and oligonucleotides common to sarcoma and transformation-defective viruses are at the poly(A) end.

Authors:  L H Wang; P Duesberg; K Beemon; P K Vogt
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

8.  The pathology of tumors and other lesions induced in rodents by virus derived from a rat with Moloney leukemia.

Authors:  F C Chesterman; J J Harvey; R R Dourmashkin; M H Salaman
Journal:  Cancer Res       Date:  1966-08       Impact factor: 12.701

9.  Studies on the nucleic acid sequences of Kirsten sarcoma virus: a model for formation of a mammalian RNA-containing sarcoma virus.

Authors:  E M Scolnick; E Rands; D Williams; W P Parks
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

10.  Harvey sarcoma virus: a second murine type C sarcoma virus with rat genetic information.

Authors:  E M Scolnick; W P Parks
Journal:  J Virol       Date:  1974-06       Impact factor: 5.103

View more
  20 in total

1.  Nucleotide sequence of the two rat cellular rasH genes.

Authors:  M Ruta; R Wolford; R Dhar; D Defeo-Jones; R W Ellis; E M Scolnick
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

2.  Biochemical properties of a highly purified v-rasH p21 protein overproduced in Escherichia coli and inhibition of its activities by a monoclonal antibody.

Authors:  S Hattori; L S Ulsh; K Halliday; T Y Shih
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

3.  An altered DNA sequence encompassing the ras gene of Harvey murine sarcoma virus.

Authors:  S Yasuda; M Furuichi; E Soeda
Journal:  Nucleic Acids Res       Date:  1984-07-25       Impact factor: 16.971

4.  An internal ribosomal entry signal in the rat VL30 region of the Harvey murine sarcoma virus leader and its use in dicistronic retroviral vectors.

Authors:  C Berlioz; C Torrent; J L Darlix
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

5.  Metabolic turnover of human c-rasH p21 protein of EJ bladder carcinoma and its normal cellular and viral homologs.

Authors:  L S Ulsh; T Y Shih
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

6.  Construction and isolation of a transmissible retrovirus containing the src gene of Harvey murine sarcoma virus and the thymidine kinase gene of herpes simplex virus type 1.

Authors:  C M Wei; M Gibson; P G Spear; E M Scolnick
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

7.  Prediction of the three-dimensional structure of the transforming region of the EJ/T24 human bladder oncogene product and its normal cellular homologue.

Authors:  M R Pincus; J van Renswoude; J B Harford; E H Chang; R P Carty; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

8.  Chromosomal mapping of the simian sarcoma virus onc gene analogue in human cells.

Authors:  D C Swan; O W McBride; K C Robbins; D A Keithley; E P Reddy; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  Identification of a precursor in the biosynthesis of the p21 transforming protein of harvey murine sarcoma virus.

Authors:  T Y Shih; M O Weeks; P Gruss; R Dhar; S Oroszlan; E M Scolnick
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

10.  Structure of a Moloney murine leukemia virus-virus-like 30 recombinant: implications for transduction of the c-Ha-ras proto-oncogene.

Authors:  A Makris; C Patriotis; S E Bear; P N Tsichlis
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.